The soluble interleukin-2 receptor as a new biological marker in diseases
Pizzolo, G.
Allergologia et Immunopathologia 19(4): 176-180
1991
ISSN/ISBN: 0301-0546 PMID: 1818519 Document Number: 370823
Document emailed within 1 workday
Related Documents
Pawlak, E.; Kochanowska, I.Ewa.; Frydecka, I.; Kiełbiński, M.; Potoczek, Sław.; Bilińska, Młgorzata. 2005: The soluble CTLA-4 receptor: a new marker in autoimmune diseases Archivum Immunologiae et Therapiae Experimentalis 53(4): 336-341Nassonov, E.L.; Samsonov, M.Y.; Tilz, G.P.; Beketova, T.V.; Semenkova, E.N.; Baranov, A.; Wachter, H.; Fuchs, D. 1997: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis Journal of Rheumatology 24(4): 666-670
Maekawa, H.; Ishiyama, N.; Furuya, N.; Nakahara, K.; Saito, S.; Uchimura, H. 1997: Serum soluble CD8 and soluble interleukin-2-receptor levels during interferon therapy in chronic hepatitis C Rinsho Byori. Japanese Journal of Clinical Pathology 45(10): 1003-1007
Ninomiya, Y.; Obara, A.; Sugawara, K.; Konishi, K. 1991: A study on interleukin 2 and soluble interleukin 2 receptor in serum and bronchoalveolar lavage fluid from patients with farmer's lung Nihon Kyobu Shikkan Gakkai Zasshi 29(11): 1399-1406
Karrer, U.; Aeschlimann, A.; Fassbender, K.; Vogt, P.; Müller, W. 1992: Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction? Schweizerische Medizinische Wochenschrift 122(7): 233-236
Alonso Fernández, J.; Roine, I.; Vasquez, A.; Cáneo, M. 2005: Soluble interleukin-2 receptor (sCD25) and interleukin-10 plasma concentrations are associated with severity of primary respiratory syncytial virus (RSV) infection European Cytokine Network 16(1): 81-90
Sun, R.X.; Gennaro, C.; Rocco, S.; Gu, Z.J.; Klein, B. 1997: Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity European Cytokine Network 8(1): 51-56
Yokoyama, A. 2005: Interleukin-6 (IL-6) /soluble IL-6 receptor Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 72-74
Herzog, C.; Herzog, A.; Aeschlimann, A.; Gerber, H.; Müller, W. 1990: Soluble interleukin 2 receptor (sIL-2R) in chronic polyarthritis Zeitschrift für Rheumatologie 49(1): 8-10
Sopeña, B.; Fernández-Rodríguez, C.M.; Martínez Vázquez, C.; Méndez, M.X.; de la Fuente, J.; Freire, M.; Arnillas, E.; Outon, A. 1998: Serum levels of soluble interleukin-2 receptor in alcoholic patients Anales de Medicina Interna 15(4): 189-193
Hsu, M.M.; Chen, Y.J.; Chang, Y.L.; Ko, J.Y.; Sheen, T.S. 1995: Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma Asian Pacific Journal of Allergy and Immunology 13(1): 1-4
Cacciola, E.; Calogero, D.; Marra, G.; Guglielmo, P. 1992: Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia Bollettino della Societa Italiana di Biologia Sperimentale 68(4): 259-262
Sheen-Chen, S.M.; Eng, H.L.; Chou, F.F.; Chen, W.J. 1998: Serum-soluble interleukin-2 receptor in patients with hepatolithiasis: a preliminary report Hepato-Gastroenterology 45(19): 196-200
Moon, Y.; Kim, Y.; Kim, M.; Lim, J.; Kang, C.S.; Kim, W.I.; Shim, S.I.; Chung, N.G.; Park, Y.H.; Min, W.S.; Han, K. 2004: Plasma soluble interleukin-2 receptor (sIL-2R) levels in patients with acute leukemia Annals of Clinical and Laboratory Science 34(4): 410-415
Sims, J.E.; Smith, D.E. 2003: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type Ii and interleukin-1 receptor accessory protein European Cytokine Network 14(2): 77-81
Marta, R.; Goette, N.; Lev, P.; Heller, P.; Kornblihtt, L.; Vassallú, P.; Glembotsky, A.; Pirola, C.; Molinas, F. 2004: Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia Haematologica 89(6): 657-663
Coaccioli, S.; Pinoca, F.; Giuliani, M.; Landucci, P.; Sabatini, C.; Puxeddu, A. 2007: Definition of adult-onset rheumatoid arthritis from elderly-onset rheumatoid arthritis by studying T-lymphocyte subpopulations, their soluble receptors and soluble receptor of interleukin-2 La Clinica Terapeutica 158(4): 303-306
Blum, H.; Wolf, M.; Enssle, K.; Röllinghoff, M.; Gessner, A. 1996: Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor Journal of Immunology 157(5): 1846-1853
Chrobák, L.; Podzimek, K.; Plísková, L.; Kerekes, Z.; Zák, P.; Voglová, J.; Spacek, J.; Palicka, V. 1996: Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia Neoplasma 43(5): 321-325
Arun, B.; Curti, B.D.; Longo, D.L.; Stevens, D.; Alvord, W.G.; Gause, B.L.; Watson, T.; Kopp, W.C.; Janik, J.E. 2000: Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia Cancer Journal From Scientific American 6(1): 21-24